Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy AcelRx Pharmaceuticals stock
Learn how to easily invest in AcelRx Pharmaceuticals stock.
AcelRx Pharmaceuticals Inc is a drug manufacturers-specialty & generic business based in the US. AcelRx Pharmaceuticals shares (ACRX) are listed on the NASDAQ and all prices are listed in US Dollars. AcelRx Pharmaceuticals employs 43 staff and has a trailing 12-month revenue of around $2.9 million.
How to buy shares in AcelRx Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ACRX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
AcelRx Pharmaceuticals stock price (NASDAQ: ACRX)Use our graph to track the performance of ACRX stocks over time.
AcelRx Pharmaceuticals shares at a glance
|Latest market close||$0.22|
|52-week range||$0.16 - $1.05|
|50-day moving average||$0.26|
|200-day moving average||$0.32|
|Wall St. target price||$4.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.28|
Buy AcelRx Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy AcelRx Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
AcelRx Pharmaceuticals price performance over time
|1 week (2022-09-28)||0.22|
|1 month (2022-09-02)||-26.67%|
|3 months (2022-07-05)||-12.00%|
|6 months (2022-04-04)||-24.14%|
|1 year (2021-10-01)||N/A|
|2 years (2020-10-05)||-83.58%|
|3 years (2019-10-04)||2.17|
|5 years (2017-10-04)||5.225|
Is AcelRx Pharmaceuticals stock undervalued or overvalued?
Valuing AcelRx Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AcelRx Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
AcelRx Pharmaceuticals's P/E ratio
AcelRx Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, AcelRx Pharmaceuticals shares trade at around 1x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
AcelRx Pharmaceuticals financials
|Revenue TTM||$2.9 million|
|Gross profit TTM||$-1,748,000|
|Return on assets TTM||-31.29%|
|Return on equity TTM||0%|
|Market capitalisation||$30.8 million|
TTM: trailing 12 months
AcelRx Pharmaceuticals share dividends
We're not expecting AcelRx Pharmaceuticals to pay a dividend over the next 12 months.
AcelRx Pharmaceuticals share price volatility
Over the last 12 months, AcelRx Pharmaceuticals's shares have ranged in value from as little as $0.16 up to $1.05. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AcelRx Pharmaceuticals's is 0.2693. This would suggest that AcelRx Pharmaceuticals's shares are less volatile than average (for this exchange).
AcelRx Pharmaceuticals overview
AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain; ARX-02, which is in Phase 2 clinical trial for the treatment of cancer breakthrough pain in opioid-tolerant patients; and 4ARX-03 for mild sedation and pain relief during painful procedures. Its product candidates also include Niyad, a regional anticoagulant for the extracorporeal circuit; and LTX-608, a nafamostat formulation for direct IV infusion being explored as an investigational product for antiviral treatment of COVID, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc.
AcelRx Pharmaceuticals in the news
AcelRx Pharmaceuticals to Participate in the H.C. Wainwright Annual Investment Conference
Frequently asked questionsWhat percentage of AcelRx Pharmaceuticals is owned by insiders or institutions?
Currently 1.196% of AcelRx Pharmaceuticals shares are held by insiders and 11.791% by institutions. How many people work for AcelRx Pharmaceuticals?
Latest data suggests 43 work at AcelRx Pharmaceuticals. When does the fiscal year end for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals's fiscal year ends in December. Where is AcelRx Pharmaceuticals based?
AcelRx Pharmaceuticals's address is: 25821 Industrial Boulevard, Hayward, CA, United States, 94545 What is AcelRx Pharmaceuticals's ISIN number?
AcelRx Pharmaceuticals's international securities identification number is: US00444T1007 What is AcelRx Pharmaceuticals's CUSIP number?
AcelRx Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 00444T100
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert